Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Tomotaka Suzuki, MD, Suguru Fukuhara, MD, Junko Nomoto, PhD, Satoshi Yamashita, PhD, Akiko Miyagi Maeshima, MD PhD, Yuta Ito, MD, Shunsuke Hatta, MD PhD, Sayako Yuda, MD PhD, Shinichi Makita, MD, PhD, Wataru Munakata, MD PhD, Tatsuya Suzuki, MD, PhD, Dai Maruyama, MD PhD, Hirokazu Taniguchi, MD, PhD, Toshikazu Ushijima, MD PhD, Koji Izutsu, MDPhD, Kensei Tobinai, MD PhD, Yukio Kobayashi, MDDSc

Blood (2018) 132 (Supplement 1): 1571.

https://doi.org/10.1182/blood-2018-99-111262

Published: 2018

Journal Articles

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

Hideaki Saito, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 3066.

https://doi.org/10.1182/blood.V124.21.3066.3066

Published: 2014

Journal Articles

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Akihisa Kawajiri, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Ken-ichi Miyamoto, MD, Suguru Fukuhara, MD, Tatsuya Suzuki, MD PhD, Wataru Munakata, MD, Yukio Kobayashi, Kinuko Tajima, Jun Itami, MD PhD, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 1761.

https://doi.org/10.1182/blood.V124.21.1761.1761

Published: 2014

Journal Articles

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Sayako Yuda, MD, Dai Maruyama, MD PhD, Akiko Miyagi Maeshima, MD PhD, Shin-ichi Makita, MD, Hideaki Kitahara, MD, Miyamoto Ken-ichi, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Tatsuya Suzuki, MD PhD, Yukio Kobayashi, MD PhD, Kinuko Tajima, Hirokazu Taniguchi, MD PhD, Kensei Tobinai

Blood (2014) 124 (21): 4475.

https://doi.org/10.1182/blood.V124.21.4475.4475

Published: 2014

Journal Articles

Clinicopathological Prognostic Indicators Of 24 Patients With B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

Ken-ichi Miyamoto, MD, Akiko Miyagi Maeshima, MD, PhD, Hirokazu Taniguchi, MD, PhD, Junko Nomoto, PhD, Hideaki Kitahara, MD, Suguru Fukuhara, MD, Wataru Munakata, MD, Dai Maruyama, MD, PhD, Sung-Won Kim, MD, PhD, Yukio Kobayashi, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2013) 122 (21): 5085.

https://doi.org/10.1182/blood.V122.21.5085.5085

Published: 2013

Journal Articles

Clinicopathologic Analysis of Follicular Lymphoma (FL) Patients with Coexisting Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Rituximab-Containing Chemotherapy

Suguru Fukuhara, MD, Dai Maruyama, MD, PhD, Ken-ichi Miyamoto, MD, Sung-Won Kim, MD, PhD, Takashi Watanabe, MD, PhD, Yukio Kobayashi, MD, PhD, Hirokazu Taniguchi, MD, PhD, Akiko Miyagi Maeshima, MD, PhD, Kensei Tobinai, MD, PhD

Blood (2012) 120 (21): 3693.

https://doi.org/10.1182/blood.V120.21.3693.3693

Published: 2012

NARROW

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Clinicopathological Prognostic Indicators Of 24 Patients With B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

Clinicopathologic Analysis of Follicular Lymphoma (FL) Patients with Coexisting Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Rituximab-Containing Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Genomics of Limited-Stage Diffuse Large B-Cell Lymphoma Developing Late Relapse: Analysis of Gene Alterations in Paired Primary and Late Relapsed Tumors By Target Sequencing

Prolonged Lymphocytepenia after Bendamustine with or without Rituximab Treatment in Patients with Relapsed or Refractory Indolent B-Cell and Mantle Cell Lymphoma

The Impact of Concurrent Expression of MYC and BCL2 on Outcomes of Localized Primary Gastric Diffuse Large B-Cell Lymphoma Undergoing Rituximab-Containing Chemotherapy with or without Radiotherapy

Influence of the Watch and Wait Strategy on the Clinical Outcome in Patients with Follicular Lymphoma in the Rituximab Era

Clinicopathological Prognostic Indicators Of 24 Patients With B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma

Clinicopathologic Analysis of Follicular Lymphoma (FL) Patients with Coexisting Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Rituximab-Containing Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only